Biotech · Private company
UCB Biopharma SRL
Track this companyFree. Adds UCB Biopharma SRL to your Dealase workspace and tells you when its record changes.
Clinical trials2521 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- bimekizumabPhase 3 · Moderate to Severe Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 3 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 3 · Palmoplantar PustulosisClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 3 · Axial SpondyloarthritisClinicalTrials.gov · fetched Nov 12, 2026
- BrivaracetamPhase 3 · Childhood Absence EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BrivaracetamPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam Film-coated tabletPhase 3 · Childhood Absence EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam oral solutionPhase 3 · Childhood Absence EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Dapirolizumab pegolPhase 3 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- DZPPhase 3 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- RozanolixizumabPhase 3 · Ocular Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- RozanolixizumabPhase 3 · Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)ClinicalTrials.gov · fetched Nov 12, 2026
- Staccato alprazolamPhase 3 · Stereotypical Prolonged SeizuresClinicalTrials.gov · fetched Nov 12, 2026
- ustekinumabPhase 3 · Moderate to Severe Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- ZilucoplanPhase 3 · Generalized Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- GalvokimigPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- GalvokimigPhase 2 · Chronic Obstructive Pulmonary Disease With Chronic BronchitisClinicalTrials.gov · fetched Nov 12, 2026
- GalvokimigPhase 2 · Non-cystic Fibrosis BronchiectasisClinicalTrials.gov · fetched Nov 12, 2026
- Bimekizumab regimen 1 ivPhase 1 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Bimekizumab regimen 2 ivPhase 1 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Bimekizumab regimen 3 scPhase 1 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- ZilucoplanPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisPHASE3 · RECRUITING · started Sep 16, 2026ClinicalTrials.gov NCT07465289 · fetched Nov 12, 2026
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis BronchiectasisPHASE2 · RECRUITING · started Aug 5, 2026ClinicalTrials.gov NCT07720375 · fetched Nov 12, 2026
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisPHASE2 · RECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07725939 · fetched Nov 12, 2026
- SLC6A1-NDD Prospective Longitudinal Natural History StudyRECRUITING · started Jul 21, 2026ClinicalTrials.gov NCT07531511 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisPHASE3 · RECRUITING · started May 27, 2026ClinicalTrials.gov NCT07463521 · fetched Nov 12, 2026
- A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 29, 2025ClinicalTrials.gov NCT07277660 · fetched Nov 12, 2026
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPHASE1 · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT07290036 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisPHASE3 · RECRUITING · started Nov 14, 2025ClinicalTrials.gov NCT07219420 · fetched Nov 12, 2026
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)PHASE1 · RECRUITING · started Nov 5, 2025ClinicalTrials.gov NCT06888193 · fetched Nov 12, 2026
- A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating WomenPHASE1 · RECRUITING · started Jul 9, 2025ClinicalTrials.gov NCT06961747 · fetched Nov 12, 2026
- A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis SuppurativaPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 7, 2025ClinicalTrials.gov NCT06921850 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusPHASE3 · RECRUITING · started Nov 21, 2024ClinicalTrials.gov NCT06617325 · fetched Nov 12, 2026
- A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisPHASE2_PHASE3 · RECRUITING · started Oct 16, 2024ClinicalTrials.gov NCT06055959 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque PsoriasisPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 29, 2024ClinicalTrials.gov NCT06506916 · fetched Nov 12, 2026
- A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence EpilepsyPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 10, 2024ClinicalTrials.gov NCT06315322 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 25, 2024ClinicalTrials.gov NCT06425549 · fetched Nov 12, 2026
- A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresPHASE3 · ENROLLING_BY_INVITATION · started Feb 3, 2022ClinicalTrials.gov NCT05076617 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)PHASE3 · ACTIVE_NOT_RECRUITING · started Feb 2, 2022ClinicalTrials.gov NCT05063162 · fetched Nov 12, 2026
- A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresPHASE3 · RECRUITING · started Dec 7, 2021ClinicalTrials.gov NCT05077904 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyPHASE3 · COMPLETED · started Jul 29, 2021ClinicalTrials.gov NCT04666610 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusPHASE3 · ENROLLING_BY_INVITATION · started Jul 27, 2021ClinicalTrials.gov NCT04976322 · fetched Nov 12, 2026
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresPHASE3 · RECRUITING · started Mar 11, 2021ClinicalTrials.gov NCT04715646 · fetched Nov 12, 2026
- A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisPHASE3 · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04436640 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaPHASE3 · COMPLETED · started Mar 2, 2020ClinicalTrials.gov NCT04242498 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaPHASE3 · COMPLETED · started Feb 19, 2020ClinicalTrials.gov NCT04242446 · fetched Nov 12, 2026